December 2025
1. ZHOU X, Li A, Kong D, Shi Y, et al
   The silent players: Atypical BCR?ABL isoforms as biomarkers and therapeutic hurdles in CML pathogenesis (Review).
   Oncol Rep. 2025;54:162.
   

   >> Share

   
   November 2025
2. SUN J, Huang X, Zeng X, Lei Y, et al
   DBN1?mediated upregulation of GAB2 facilitates the migration and invasion of T?cell acute lymphoblastic leukemia cells.
   Oncol Rep. 2025;54:149.
   

   >> Share

   
   October 2025
3. YU Y, Duan S, He J, Liang W, et al
   [Corrigendum] Highly sensitive detection of leukemia cells based on aptamer and quantum dots.
   Oncol Rep. 2025;54:129.
   

   >> Share

   
   September 2025
4. CHEN N, Feng L, Qu H, Lu K, et al
   [Corrigendum] Overexpression of IL?9 induced by STAT3 phosphorylation is mediated by miR?155 and miR?21 in chronic lymphocytic leukemia.
   Oncol Rep. 2025;54:107.
   

   >> Share

   
   August 2025
5. LI L, Gorgens A, Mussack V, Pepeldjiyska E, et al
   Role of extracellular vesicles as promotors for activation of leukemia?derived dendritic cell?mediated antileukemic immune response against AML?blasts.
   Oncol Rep. 2025;54:99.
   

   >> Share

   
   July 2025
6. WANG C, Yang X, Shen X, Yan S, et al
   SNX10 regulates the proliferation, apoptosis and cell cycle of acute B lymphoblastic leukemia cells via the PI3K/Akt signaling pathway.
   Oncol Rep. 2025;54:78.
   

   >> Share

   
   May 2025
7. QIU H, Zhang C, Ma X, Li Y, et al
   Molecular insights and treatment innovations: Advancing outcomes in acute myeloid leukemia with myelodysplasia?related changes (Review).
   Oncol Rep. 2025;53:54.
   

   >> Share

   
   March 2025
8. LIU YH, Zhu M, Lei PP, Pan XY, et al
   [Corrigendum] ND?09 inhibits chronic myeloid leukemia K562 cell growth by regulating BCR?ABL signaling.
   Oncol Rep. 2025;53:37.
   

   >> Share

   
   November 2024
9. CHEN L, Zeng P, Tang H, Chen G, et al
   Routes and molecular mechanisms of central nervous system involvement in acute myeloid leukemia (Review).
   Oncol Rep. 2024;52:146.
   

   >> Share

   
   August 2024
10. MORINO Y, Sugiyama H, Yamane K, Kikuchi M, et al
    Additive antitumor effect of arsenic trioxide with exposure to ionizing radiation to human acute promyelocytic leukemia HL?60 cells.
    Oncol Rep. 2024;52:109.
    

    >> Share

    
    July 2024
11. IDA N, Okura M, Tanaka S, Hosono N, et al
    Combining inotuzumab ozogamicin with PARP inhibitors olaparib and talazoparib exerts synergistic cytotoxicity in acute lymphoblastic leukemia by inhibiting DNA strand break repair.
    Oncol Rep. 2024;52:90.
    

    >> Share

    
    May 2024
12. TENG Z, Xu S, Lei Q
    [Retracted] Tanshinone IIA enhances the inhibitory effect of imatinib on proliferation and motility of acute leukemia cell line TIB?152 in vivo and in vitro by inhibiting the PI3K/AKT/mTOR signaling pathway.
    Oncol Rep. 2024;51:66.
    

    >> Share

    
    December 2023
13. LI J, Tang B, Miao Y, Li G, et al
    Targeting of STAT5 using the small molecule topotecan hydrochloride suppresses acute myeloid leukemia progression.
    Oncol Rep. 2023;50:208.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share